Management

Søren Bregenholt
CEO
    • Independent in relation to the Company and its management: No
    • Independent in relation to major shareholders: Yes
    • Holdings in Alligator: 279,496 shares and 500,000 warrants in program TO 2022/2025 I.
    • Other current positions: Chairman of Medicon Valley Alliance, Chairman of A Bioscience Incentive AB and Atlas Therapeutics AB
    Malin Carlsson
    EVP & COO
      • Independent in relation to the Company and its management: Yes
      • Independent in relation to major shareholders: Yes
      • Holdings in Alligator: 10,000 shares and 250,000 warrants in program TO 2022/2025 I.
      • Other current positions: Deputy Board member in A Bioscience Incentive AB and Atlas Therapeutics AB.
      Peter Ellmark
      CSO
        • Independent in relation to the Company and its management: Yes
        • Independent in relation to major shareholders: Yes
        • Holdings in Alligator: 40,000 shares and 250,000 warrants in program TO 2022/2025 I.
        • Other current positions: None
        Marie Svensson
        CFO
          • Independent in relation to the Company and its management: No
          • Independent in relation to major shareholders: Yes
          • Holdings in Alligator: 60,000 shares and 250,000 warrants in program TO 2022/2025 I.
          • Other current positions: Board member of A Bioscience Incentive AB and Atlas Therapeutics AB, Deputy board member in Lemniscus Consulting AB.
          Updated 2022-08-24